Veterinary Molecular Diagnostics Market Future Demands, Growth Analysis and Forecast 2021-2030

(Market Stats News via Comtex)

According to Report, the global veterinary molecular diagnostics market size is projected to surpass at US$ 1.5 billion by 2030 and is expected to expand at a CAGR of 8.8% from 2021 to 2030. Molecular diagnostics are laboratory methods to examine the RNA, DNA, or other proteins in animals and identify diseases or the predisposition stage. Different technologies are used in the diagnosis of veterinary diseases, including conventional PCR, singleplex PCR, multiplex PCR, and real-time PCR. The growth of the global veterinary molecular diagnostics market can be ascribed to increase in zoonotic disease concerns and rise in pet ownership & spending in the pet industry. North America dominated the global veterinary molecular diagnostics market in 2019. The trend is anticipated to continue during the forecast period. Highly structured healthcare industry, early adoption of new products, high prevalence rate of zoonotic diseases, and presence of major players are expected to drive the veterinary molecular diagnostics market in North America.

Asia Pacific is likely to be a highly lucrative market for veterinary molecular diagnostics during the forecast period. The market in the region is projected to expand at a high CAGR from 2020 to 2030.

Get the sample pages of [email protected] https://www.visionresearchreports.com/report/sample/35970

Growth Drivers

  • In the years to come, the global veterinary molecular diagnostics market is predicted to be driven by a spike in pet obesity and increased knowledge of veterinary diagnostics.
  • New vaccines and new breakthroughs in molecular diagnostic veterinary techniques are anticipated to improve the management and overall condition of a spectrum of illnesses in veterinary molecules, by using a genomic approach.

In the coming years, research and development is likely to be a key contributor to the global veterinary molecular diagnostics market. Few of the latest groundbreaking and novel innovations in animal health diagnostics and therapeutic methods are predicted to open up new opportunities for the players in the global veterinary molecular diagnostics market. Significant progress in the identification, control, and treatment of various non-infectious and infectious diseases in animals is anticipated to strengthen demand for these diagnostics in the years to come.

Advances in research, technology, and rising investments from both non-private and private business organisations are likely to drive innovations in the field of veterinary molecular diagnostics. Advancement made in veterinary molecular diagnostics has also bolstered the food security and economies in a number of developing countries, including China and India. This factor is anticipated to support the expansion of global veterinary molecular diagnostics market over the period of assessment. Veterinary molecular diagnostic methods, both traditional and contemporary, play a crucial role in the identification and detection of both emerging as well as new pathogens in livestock, which is why adoption rates are continuing to rise.

Increase in Zoonotic Disease Concerns and Rise in Pet Ownership & Spending in Pet Industry to Drive Global Market

A disease that spreads between animals and humans is termed as zoonotic disease. It can be caused by viruses, bacteria, parasites, and fungi. Scientists estimate that more than six in 10 infectious diseases in humans are spread from animals. Prevalence of several zoonotic and vector-borne diseases are likely to increase in the near future due to changing social habits, habitat modification, exotic vector introductions, and climate change. Hence, the need of development of rapid and precise diagnosis methods for the prevention of these diseases is anticipated to drive the global veterinary molecular diagnostics market. Rise in pet ownership and spending in the pet industry is another major factor boosting the growth of the global market. According to a survey conducted by the American Pet Products Association (APPA), in 2019-2020, 67% of the U.S. households or about 85 million families, own a pet.

According to a report published by the Federal Trade Commission (FTC), in 2018, the U.S. Government spent around US$ 72.5 Bn on the pet industry, which included food, veterinary care, prescription, and OTC medications, and other pet services and products.

Kits & Reagents to Dominate Veterinary Molecular Diagnostics Market

In terms of product type, the global veterinary molecular diagnostics market has been divided into instruments & software, kits & reagents, and services. The kits & reagents segment dominated the global veterinary molecular diagnostics market in 2019. The trend is likely to continue during the forecast period. This can be attributed to increase in demand for customized reagents and kits. A second wave of automation, which includes replacement of existing old technology and low throughput automated systems with advanced fully automated and high throughput systems, is anticipated to lead to uptake of automated veterinary molecular diagnostic analyzer units in the market.

Moreover, consolidation among diagnostic laboratories and rise in demand for small volume point-of-care automated veterinary molecular diagnostic analyzer systems are projected to fuel the growth of the segment. Instruments & software was the second largest segment in terms of market share in 2019. The growth of the segment can be attributed to advantages of automated instruments & software such as quick results with less labor.

Real-time PCR to be Highly Lucrative Technology

Based on technology, the global veterinary molecular diagnostics market has been categorized into conventional PCR, singleplex PCR, multiplex PCR, real-time PCR, and others. The real-time PCR segment accounted for prominent share of the global veterinary molecular diagnostics market in 2019. Real-time PCR has higher precision, increased sensitivity (down to one copy), increased dynamic range (greater than 8 logs), and high resolution (less than two-fold differences). These factors are likely to boost the growth of the segment during the forecast period.

Vector-borne Diseases to Offer Growth Opportunities

In terms of disease type, the global veterinary molecular diagnostics market has been categorized into vector-borne diseases, respiratory pathogens, diarrhea pathogens, and others. The vector-borne diseases segment accounted for major share of the global veterinary molecular diagnostics market in 2019. This can be ascribed to rise in awareness about diseases transmitted by common ectoparasites such as ticks, mosquitos, and fleas. Trypanosomiasis is one of the major vector-born animal disease constraints to livestock production. For instance, in sub-Saharan Africa, this disease affects meat production, which is reduced by 5% to 30% and milk production from 10% to 40%.

Companion Animals to be Highly Lucrative Segment

Based on animal type, the global veterinary molecular diagnostics market has been bifurcated into companion animals and livestock animals. The companion animals segment has been split into canine, feline, and others. The companion animals segment accounted for a prominent share of the global veterinary molecular diagnostics market in 2019 due to rise in pet ownership in North America and Europe. According to the European Pet Food Industry Federation, over 75 million households in Europe own a pet each. This number is expected to rise exponentially in the near future.

Hospital and Clinics to be Major End Users

In terms of end user, the global veterinary molecular diagnostics market has been segregated into hospitals/clinics and reference laboratories. The reference laboratories segment led the global veterinary molecular diagnostics market in terms of revenue in 2019. The trend is expected to continue during the forecast period. Reference laboratories are dedicated facilities, which have all the necessary reagents, kits, instruments, software, and technicians with the required skill set to perform sophisticated molecular diagnostic tests. This makes reference laboratories the preferred choice of most of the veterinary hospitals and clinics for their diagnostic needs, especially small private clinics and hospitals. These factors are expected to fuel the growth of the reference laboratories segment during the forecast period.

Buy this premium research report, click [email protected] https://www.visionresearchreports.com/report/cart/35970 OR Call: +1 9197 992 333

North America to Dominate Veterinary Molecular Diagnostics Market

In terms of region, the global veterinary molecular diagnostics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global veterinary molecular diagnostics market in 2019, followed by Europe. North America is also home to several key players such as Idexx, VCA, and Thermo Fisher. Additionally, increase in pet ownership in the U.S. is likely to fuel the growth of the market in North America. According to a survey conducted by the American Pet Products Association (APPA), in 2017-2018, around 94.2 million cats and 89.7 million dogs were owned as pets in the U.S.

The veterinary molecular diagnostics market in Asia Pacific is anticipated to expand at a high CAGR from 2020 to 2030. This can be ascribed to the high adoption of veterinary diagnostic products for the well-being of the rapidly increasing livestock animal population.

Competition Landscape

The global veterinary molecular diagnostics market is fragmented in terms of number of players. Key players operating in the global market include IDEXX Laboratories, Inc., Thermo Fisher Scientific, Inc., Zoetis, Inc., Neogen Corporation, bioMerieux SA, QIAGEN N.V., Biomedica Medizinprodukte GmbH & Co KG, Bioneer, VCA, Inc. (subsidiary of Mars, Incorporated), and ID.VET.

Market Segmentation

By Product Type

    • Instruments & Software
    • Kits & Reagents
    • Services

By Technology

    • Conventional PCR
    • Singleplex PCR
    • Multiplex PCR
    • Real-time PCR
    • Others

By Disease Type

    • Vector-borne Diseases
    • Respiratory Pathogens
    • Diarrhea Pathogens
    • Others

By Animal Type

    • Companion Animal
    • Canine
    • Feline
    • Others
    • Livestock Animal

By End User

    • Hospitals/Clinics
    • Reference Laboratories

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Scope of the Report

VRR's report on the global veterinary molecular diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the market during the forecast period from 2020 to 2030. The report provides revenue of the global veterinary molecular diagnostics market for the period 2018-2030, considering 2020 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global veterinary molecular diagnostics market from 2020 to 2030.

The report is prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the veterinary molecular diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global veterinary molecular diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global veterinary molecular diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global veterinary molecular diagnostics market.

The report delves into the competition landscape of the global veterinary molecular diagnostics market. Key players operating in the global veterinary molecular diagnostics market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global veterinary molecular diagnostics market profiled in this report.

Key Questions Answered in Veterinary Molecular Diagnostics Market Report

  1. What is the sales/revenue generated by veterinary molecular diagnostics across all regions during the forecast period?
  2. What are the opportunities in the global veterinary molecular diagnostics market?
  3. What are the major drivers, restraints, opportunities, and threats in the market?
  4. Which regional market is set to expand at the fastest CAGR during the forecast period?
  5. Which product type segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
  6. What are the market positions of different companies operating in the global market?

Research Objectives and Research Approach

The comprehensive report on the global veterinary molecular diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global veterinary molecular diagnostics market in terms of product type, technology, disease type, animal type, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2030 has also been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global veterinary molecular diagnostics market.

Table of Content

  1. Preface

1.1. Report Scope and Market Segmentation

1.2. Research Highlights

  1. Assumptions and Research Methodology

2.1. Assumptions and Acronyms Used

2.2. Research Methodology

  1. Executive Summary
  2. Market Overview

4.1. Introduction

4.2. Key Industry Developments

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunity

4.4. Global Veterinary Molecular Diagnostics Market Forecast

4.5. Global Veterinary Molecular Diagnostics Market Outlook

  1. Market Outlook

5.1. Key Industrial Events (Licensing Partnership/Merger & Acquisition)

5.2. Pet Ownership Statistics

5.3. List of Pathogens for responsible for Canine, Feline, and Equine Diseases

5.4. Covid-19 Impact Analysis

5.5. Pros and Cons of Each Type of PCR Test

5.6. Technological Advancement

5.7. Most commonly Used Instruments for Veterinary Diagnostics

5.8. Veterinary Medical Device Regulation

  1. Global Veterinary Molecular Diagnostics Market Analysis, by Product Type

6.1. Introduction

6.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type

6.3. Global Veterinary Molecular Diagnostics Market Forecast, by Product Type

6.3.1. Instruments & Software

6.3.2. Kits & Reagents

6.3.3. Services

6.4. Global Veterinary Molecular Diagnostics Market Analysis, by Product Type

  1. Global Veterinary Molecular Diagnostics Market Analysis, by Technology

7.1. Introduction

7.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology

7.3. Global Veterinary Molecular Diagnostics Market Forecast, by Technology

7.3.1. Conventional PCR

7.3.2. Singleplex PCR

7.3.3. Multiplex PCR

7.3.4. Real-time PCR

7.3.5. Others

7.4. Global Veterinary Molecular Diagnostics Market Analysis, by Technology

  1. Global Veterinary Molecular Diagnostics Market Analysis, by Disease Type

8.1. Introduction

8.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type

8.3. Global Veterinary Molecular Diagnostics Market Forecast, by Disease Type

8.3.1. Vector-borne Diseases

8.3.2. Respiratory Pathogens

8.3.3. Diarrhea Pathogens

8.3.4. Others

8.4. Global Veterinary Molecular Diagnostics Market Analysis, by Disease Type

  1. Global Veterinary Molecular Diagnostics Market Analysis, by Animal Type

9.1. Introduction

9.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type

9.3. Global Veterinary Molecular Diagnostics Market Forecast, by Animal Type

9.3.1. Companion Animals

9.3.1.1. Canine

9.3.1.2. Feline

9.3.1.3. Others

9.3.2. Livestock Animals

9.4. Global Veterinary Molecular Diagnostics Market Analysis, by Animal Type

  1. Global Veterinary Molecular Diagnostics Market Analysis, by End-user

10.1. Introduction

10.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user

10.3. Global Veterinary Molecular Diagnostics Market Forecast, by End-user

10.3.1. Hospitals/Clinics

10.3.2. Reference Laboratories

10.4. Global Veterinary Molecular Diagnostics Market Analysis, by End-user

  1. Global Veterinary Molecular Diagnostics Market Analysis, by Region

11.1. Global Veterinary Molecular Diagnostics Market Scenario, by Region/Country

11.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Region

11.3. Global Veterinary Molecular Diagnostics Market Forecast, by Region

11.3.1. North America

11.3.2. Europe

11.3.3. Asia Pacific

11.3.4. Latin America

11.3.5. Middle East & Africa

  1. North America Veterinary Molecular Diagnostics Market Analysis

12.1. North America Veterinary Molecular Diagnostics Market Overview

12.2. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country

12.3. North America Veterinary Molecular Diagnostics Market Forecast, by Country

12.3.1. U.S.

12.3.2. Canada

12.4. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type

12.5. North America Veterinary Molecular Diagnostics Market Forecast, by Product Type

12.5.1. Instruments & Software

12.5.2. Kits & Reagents

12.5.3. Services

12.6. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology

12.7. North America Veterinary Molecular Diagnostics Market Forecast, by Technology

12.7.1. Conventional PCR

12.7.2. Singleplex PCR

12.7.3. Multiplex PCR

12.7.4. Real-time PCR

12.7.5. Others

12.8. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type

12.9. North America Veterinary Molecular Diagnostics Market Forecast, by Disease Type

12.9.1. Vector-borne Diseases

12.9.2. Respiratory Pathogens

12.9.3. Diarrhea Pathogens

12.9.4. Others

12.10. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type

12.11. North America Veterinary Molecular Diagnostics Market Forecast, by Animal Type

12.11.1. Companion Animals

12.11.1.1. Canine

12.11.1.2. Feline

12.11.1.3. Others

12.11.2. Livestock Animals

12.12. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user

12.13. North America Veterinary Molecular Diagnostics Market Forecast, by End-user

12.13.1. Hospitals/Clinics

12.13.2. Reference Laboratories

  1. Europe Veterinary Molecular Diagnostics Market Analysis

13.1. Europe Veterinary Molecular Diagnostics Market Overview

13.2. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region

13.3. Europe Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region

13.3.1. Germany

13.3.2. U.K.

13.3.3. France

13.3.4. Italy

13.3.5. Spain

13.3.6. Rest of Europe

13.4. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type

13.5. Europe Veterinary Molecular Diagnostics Market Forecast, by Product Type

13.5.1. Instruments & Software

13.5.2. Kits & Reagents

13.5.3. Services

13.6. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology

13.7. Europe Veterinary Molecular Diagnostics Market Forecast, by Technology

13.7.1. Conventional PCR

13.7.2. Singleplex PCR

13.7.3. Multiplex PCR

13.7.4. Real-time PCR

13.7.5. Others

13.8. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type

13.9. Europe Veterinary Molecular Diagnostics Market Forecast, by Disease Type

13.9.1. Vector-borne Diseases

13.9.2. Respiratory Pathogens

13.9.3. Diarrhea Pathogens

13.9.4. Others

13.10. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type

13.11. Europe Veterinary Molecular Diagnostics Market Forecast, by Animal Type

13.11.1. Companion Animals

13.11.1.1. Canine

13.11.1.2. Feline

13.11.1.3. Others

13.11.2. Livestock Animals

13.12. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user

13.13. Europe Veterinary Molecular Diagnostics Market Forecast, by End-user

13.13.1. Hospitals/Clinics

13.13.2. Reference Laboratories

  1. Asia Pacific Veterinary Molecular Diagnostics Market Analysis

14.1. Asia Pacific Veterinary Molecular Diagnostics Market Overview

14.2. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region

14.3. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region

14.3.1. China

14.3.2. Japan

14.3.3. India

14.3.4. Australia & New Zealand

14.3.5. Rest of Asia Pacific

14.4. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type

14.5. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Product Type

14.5.1. Instruments & Software

14.5.2. Kits & Reagents

14.5.3. Services

14.6. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology

14.7. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Technology

14.7.1. Conventional PCR

14.7.2. Singleplex PCR

14.7.3. Multiplex PCR

14.7.4. Real-time PCR

14.7.5. Others

14.8. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type

14.9. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Disease Type

14.9.1. Vector-borne Diseases

14.9.2. Respiratory Pathogens

14.9.3. Diarrhea Pathogens

14.9.4. Others

14.10. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type

14.11. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Animal Type

14.11.1. Companion Animals

14.11.1.1. Canine

14.11.1.2. Feline

14.11.1.3. Others

14.11.2. Livestock Animals

14.12. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user

14.13. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by End-user

14.13.1. Hospitals/Clinics

14.13.2. Reference Laboratories

  1. Latin America Veterinary Molecular Diagnostics Market Analysis

15.1. Latin America Veterinary Molecular Diagnostics Market Overview

15.2. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region

15.3. Latin America Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region

15.3.1. Brazil

15.3.2. Mexico

15.3.3. Rest of Latin America

15.4. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type

15.5. Latin America Veterinary Molecular Diagnostics Market Forecast, by Product Type

15.5.1. Instruments & Software

15.5.2. Kits & Reagents

15.5.3. Services

15.6. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology

15.7. Latin America Veterinary Molecular Diagnostics Market Forecast, by Technology

15.7.1. Conventional PCR

15.7.2. Singleplex PCR

15.7.3. Multiplex PCR

15.7.4. Real-time PCR

15.7.5. Others

15.8. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type

15.9. Latin America Veterinary Molecular Diagnostics Market Forecast, by Disease Type

15.9.1. Vector-borne Diseases

15.9.2. Respiratory Pathogens

15.9.3. Diarrhea Pathogens

15.9.4. Others

15.10. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type

15.11. Latin America Veterinary Molecular Diagnostics Market Forecast, by Animal Type

15.11.1. Companion Animals

15.11.1.1. Canine

15.11.1.2. Feline

15.11.1.3. Others

15.11.2. Livestock Animals

15.12. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user

15.13. Latin America Veterinary Molecular Diagnostics Market Forecast, by End-user

15.13.1. Hospitals/Clinics

15.13.2. Reference Laboratories

  1. Middle East & Africa Veterinary Molecular Diagnostics Market Analysis

16.1. Middle East & Africa Veterinary Molecular Diagnostics Market Overview

16.2. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region

16.3. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region

16.3.1. GCC Countries

16.3.2. South Africa

16.3.3. Rest of Middle East & Africa

16.4. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type

16.5. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Product Type

16.5.1. Instruments & Software

16.5.2. Kits & Reagents

16.5.3. Services

16.6. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology

16.7. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Technology

16.7.1. Conventional PCR

16.7.2. Singleplex PCR

16.7.3. Multiplex PCR

16.7.4. Real-time PCR

16.7.5. Others

16.8. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type

16.9. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Disease Type

16.9.1. Vector-borne Diseases

16.9.2. Respiratory Pathogens

16.9.3. Diarrhea Pathogens

16.9.4. Others

16.10. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type

16.11. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Animal Type

16.11.1. Companion Animals

16.11.1.1. Canine

16.11.1.2. Feline

16.11.1.3. Others

16.11.2. Livestock Animals

16.12. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user

16.13. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by End-user

16.13.1. Hospitals/Clinics

16.13.2. Reference Laboratories

  1. Competition Landscape

17.1. Competition Matrix

17.2. Global Veterinary Molecular Diagnostics Market Share Analysis, by Company

17.3. Company Profiles

17.3.1. IDEXX Laboratories, Inc.

17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

17.3.1.2. Financial Overview

17.3.1.3. Product Portfolio

17.3.1.4. SWOT Analysis

17.3.1.5. Strategic Overview

17.3.2. Thermo Fisher Scientific, Inc.

17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

17.3.2.2. Financial Overview

17.3.2.3. Product Portfolio

17.3.2.4. SWOT Analysis

17.3.2.5. Strategic Overview

17.3.3. Zoetis, Inc.

17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

17.3.3.2. Financial Overview

17.3.3.3. Product Portfolio

17.3.3.4. SWOT Analysis

17.3.3.5. Strategic Overview

17.3.4. Neogen Corporation

17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

17.3.4.2. Product Portfolio

17.3.4.3. SWOT Analysis

17.3.4.4. Strategic Overview

17.3.5. bioMerieux SA

17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

17.3.5.2. Financial Overview

17.3.5.3. Product Portfolio

17.3.5.4. SWOT Analysis

17.3.5.5. Strategic Overview

17.3.6. QIAGEN N.V.

17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

17.3.6.2. Financial Overview

17.3.6.3. Product Portfolio

17.3.6.4. SWOT Analysis

17.3.6.5. Strategic Overview

17.3.7. Biomedica Medizinprodukte GmbH & Co KG

17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

17.3.7.2. Product Portfolio

17.3.7.3. SWOT Analysis

17.3.7.4. Strategic Overview

17.3.8. Bioneer

17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

17.3.8.2. Product Portfolio

17.3.8.3. SWOT Analysis

17.3.8.4. Strategic Overview

17.3.9. VCA, Inc. (subsidiary of Mars, Incorporated)

17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

17.3.9.2. Product Portfolio

17.3.9.3. SWOT Analysis

17.3.9.4. Strategic Overview

17.3.10. ID.VET

17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

17.3.10.2. Product Portfolio

17.3.10.3. SWOT Analysis

17.3.10.4. Strategic Overview

Buy this premium research report, click [email protected] https://www.visionresearchreports.com/report/cart/35970 OR Call: +1 9197 992 333

The post Veterinary Molecular Diagnostics Market Future Demands, Growth Analysis and Forecast 2021-2030 appeared first on Market Stats News.

comtex tracking

COMTEX_388139742/2746/2021-06-11T09:21:45